Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ: NEO )

14.77 -3.84 (-20.63%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about NeoGenomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. 
Via Benzinga
US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit
Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from  
Via Benzinga
Stocks Edge Higher As End Of 2023 Approaches
The SPX is less than 10 points away from record close territory, and with one day left, all three major indexes are heading toward sizable December wins. 
Via Talk Markets
7 Analysts Have This To Say About NeoGenomics
Via Benzinga
What 6 Analyst Ratings Have To Say About NeoGenomics
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
Where NeoGenomics Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
NeoGenomics, Energy Fuels And Other Big Stocks Moving Lower On Thursday
U.S. stocks traded higher, with the Dow Jones index gaining around 80 points on Thursday. Shares of NeoGenomics, Inc. (NASDAQ: NEO) shares fell sharply during Thursday’s session after Natera won a... 
Via Benzinga
Topics Intellectual Property Lawsuit Stocks
Exposures Financial Intellectual Property Legal
Bull Of The Day: NeoGenomics
NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
4 Analysts Have This to Say About NeoGenomics
Via Benzinga
NeoGenomics Raises Annual Guidance After Solid Q2 Earnings Beat
NeoGenomics, Inc. (NASDAQ: NEO) reported Q2 revenues of $146.92 million, +18% Y/Y, beating the  
Via Benzinga
NeoGenomics's Return On Capital Employed Insights
Via Benzinga
Earnings Scheduled For August 11, 2023
Companies Reporting Before The Bell • Consolidated Water Co (NASDAQ:CWCO) is estimated to report quarterly earnings at $0.22 per share on revenue of $30.27 million. 
Via Benzinga
Guardant Health Stock Reaches 80-Plus Relative Strength Rating Benchmark
On Friday, Guardant Health stock hit a key performance benchmark, with its Relative Strength Rating rising to 82, up from 78 the day before. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
Via Benzinga
NeoGenomics: Q1 Earnings Insights
Via Benzinga
NeoGenomics Reports Q1 Topline Growth, Lifts Annual Guidance, Shares Soar
NeoGenomics Inc (NASDAQ: NEO) reported Q1 revenues of $137.22 mill 
Via Benzinga
Analyst Expectations for NeoGenomics's Future
Via Benzinga
What 9 Analyst Ratings Have To Say About NeoGenomics
Via Benzinga
Earnings Scheduled For May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter. 
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. 
Via Benzinga
Looking Into NeoGenomics's Return On Capital Employed
Via Benzinga
Analyst Ratings for NeoGenomics
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
Via Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing
The high-flyers have soared to new heights and further gains could be up ahead. 
Via The Motley Fool
Cowen & Co. Maintains Outperform Rating for NeoGenomics: Here's What You Need To Know
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.